NICE technology appraisal guidance
Issued: November 2006
TA111

Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta111

Important information about this guidance

This guidance has been updated and replaced by NICE technology appraisal 217.